Putamen dopamine transporter and glucose metabolism are reduced in SCA17
- 29 August 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 58 (3) , 490-491
- https://doi.org/10.1002/ana.20609
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Dopamine Transporter Positron Emission Tomography in Spinocerebellar Ataxias Type 1, 2, 3, and 6Archives of Neurology, 2005
- Reduced striatal [123I]FP‐CIT binding in SCA2 patients without parkinsonismAnnals of Neurology, 2004
- Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17)Annals of Neurology, 2003
- Extrapyramidal Motor Signs in Degenerative AtaxiasArchives of Neurology, 2000
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997